tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Promising Growth Potential for Dogwood Therapeutics with Halneuron’s Development and Strong Financial Position
PremiumRatingsPromising Growth Potential for Dogwood Therapeutics with Halneuron’s Development and Strong Financial Position
3M ago
Buy Rating for Dogwood Therapeutics Driven by Promising Clinical Developments and Strong Financial Outlook
Premium
Ratings
Buy Rating for Dogwood Therapeutics Driven by Promising Clinical Developments and Strong Financial Outlook
3M ago
Dogwood Therapeutics Reports Progress in Pain Treatment Trials
Premium
Company Announcements
Dogwood Therapeutics Reports Progress in Pain Treatment Trials
3M ago
Dogwood upgraded to Buy from Neutral at H.C. Wainwright
PremiumThe FlyDogwood upgraded to Buy from Neutral at H.C. Wainwright
4M ago
Dogwood receives Nasdaq confirmation of compliance
Premium
The Fly
Dogwood receives Nasdaq confirmation of compliance
4M ago
Dogwood management to meet with Maxim
Premium
The Fly
Dogwood management to meet with Maxim
4M ago
Biotech Alert: Searches spiking for these stocks today
PremiumThe FlyBiotech Alert: Searches spiking for these stocks today
5M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
5M ago
Dogwood prices 578,950 shares at $8.26 in registered direct offering
Premium
The Fly
Dogwood prices 578,950 shares at $8.26 in registered direct offering
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100